[ORGANIZATION]
BioArctic AB
Featured in 2 tracked stories · first seen
Situations
Leqembi Alzheimer's treatment availability and application
2 clusters · 4 sources · last updated
Latest: Pohang Semyung Christianity Hospital reports first patient to complete 18-month Leqembi treatment
The Alzheimer’s disease medication Leqembi, a monoclonal antibody designed to target amyloid-beta plaques, has seen expanded availability and clinical application. In the United States, Eisai announced the availability
Also covered in
-
BioArctic to release Q2 2026 financial report on August 26
[BUSINESS] · 2 sources ·